The medicines regulator has given provisional approval to a Pfizer COVID-19 vaccine booster for children aged five to 11.
However, the Therapeutic Goods Administration (TGA) said in a statement on Wednesday the government's decision on the use of this vaccine as a booster in this age group would be informed by advice from the Australian Technical Advisory Group on Immunisation (ATAGI).
At its most recent meeting, ATAGI considered evidence in relation to the Pfizer booster for five to 11 year olds, including disease burden, durability of protection against infection and severe disease, safety, and international recommendations.
